Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asenapine vs Placebo and Olanzapine in Schizophrenia
NCT00151424Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Feb 2005
- Primary completion
- Jan 2006
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of asenapine in schizophrenia (3 arms), sponsored by Organon & Co. Primary endpoint: Positive and Negative Syndrome Scale Total at 6 weeks. Started Feb 2005; status: completed.
02
Drugs
asenapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00151424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151424.